PPARγ Agonists: Potential as Therapeutics for Neovascular Retinopathies

Silswal, N., Parelkar, N. K., Wacker, M. J., Badr, M., & Andresen, J. (2012). PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists. PPAR Research, 2012(), 176-185. https://doi.org/10.1155/2012/302495
Serghides, L. (2012). The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria. PPAR Research, 2012(), 399-410. https://doi.org/10.1155/2012/513865
Belfiore, A., Genua, M., & Malaguarnera, R. (2009). PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer. PPAR Research, 2009(), 331-348. https://doi.org/10.1155/2009/830501
Junior, L. F. D. R., Dantas, A. T., Duarte, Â. L. B. P., Rego, M. J. B. D. M., Pitta, I. D. R., & Pitta, M. G. D. R. (2013). PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?. PPAR Research, 2013(), 143-151. https://doi.org/10.1155/2013/519724
Haidaris, P. J. S., Pollock, S. J., Ramon, S., Guo, N., Woeller, C. F., Feldon, S. E., & Phipps, R. P. (2010). Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. PPAR Research, 2010(), 625-660. https://doi.org/10.1155/2010/814609